PJP
Invesco Pharmaceuticals ETF
1W: -4.7%
1M: -7.0%
3M: +0.7%
YTD: +15.8%
1Y: +27.3%
3Y: +68.2%
5Y: +60.4%
$120.88
-0.36 (-0.30%)
Weekly Expected Move ±2.4%
$115
$118
$121
$124
$127
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
58.2
★★★★★
Altman Z-Score
5.27
Safe
Weight Coverage
100%
of portfolio analyzed
Holdings Matched
27
with fundamental data
InsiderStreet Scorecard
★★★★★
58.2
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
5.27
Safe Zone (>2.99)
Piotroski F-Score
6.2 / 9
Moderate
Beneish M-Score
-2.47
Unlikely Manipulator
Credit Score
—
Earnings Quality
57.4 / 100
Portfolio Valuation
P/E
40.11x
P/B
8.97x
P/S
6.22x
EV/EBITDA
22.89x
EV/Revenue
6.90x
P/FCF
25.99x
P/OCF
21.86x
PEG
5.94x
Earnings Yield
2.49%
FCF Yield
3.85%
OCF Yield
4.58%
Median P/E
17.60x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+19.7%
Net Income
+31.7%
EPS
+33.3%
FCF
+34.8%
EBITDA
+31.0%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+22.2%
Rev CAGR 5Y
+12.5%
EPS CAGR 3Y
+6.8%
EPS CAGR 5Y
+10.8%
FCF CAGR 3Y
+14.9%
FCF CAGR 5Y
+8.3%
EBITDA CAGR 3Y
+14.0%
EBITDA CAGR 5Y
+7.0%
Payout Ratio
63.50%
Buyback Yield
1.13%
Dividend Yield
1.63%
Total Shareholder Return
2.23%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$120.88
Median 1Y
$133.32
5th Pctile
$99.29
95th Pctile
$178.86
Ann. Volatility
18.8%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 40.11 |
| Portfolio P/B | 8.97 |
| Portfolio P/S | 6.22 |
| EV/EBITDA | 22.89 |
| EV/Revenue | 6.90 |
| P/FCF | 25.99 |
| P/OCF | 21.86 |
| PEG | 5.94 |
| Earnings Yield | 2.49% |
| FCF Yield | 3.85% |
| OCF Yield | 4.58% |
| Median P/E | 17.60 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 72.59% |
| Operating Margin | 25.74% |
| Net Margin | 14.61% |
| FCF Margin | 23.89% |
| ROE | 21.39% |
| ROA | 6.90% |
| ROIC | 15.59% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 1.20 |
| Debt/Assets | 0.38 |
| Net Debt/EBITDA | 2.17 |
| Interest Coverage | 8.25 |
| Current Ratio | 1.26 |
| Quick Ratio | 0.99 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 19.68% |
| Net Income Growth | 31.69% |
| EPS Growth | 33.31% |
| FCF Growth | 34.78% |
| EBITDA Growth | 30.99% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 22.16% |
| Revenue CAGR 5Y | 12.47% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 6.75% |
| EPS CAGR 5Y | 10.75% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 14.95% |
| FCF CAGR 5Y | 8.32% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 13.96% |
| EBITDA CAGR 5Y | 6.99% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 6.89% |
| Net Income CAGR 5Y | 11.58% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 58.2 |
| IS Profitability | 56.3 |
| IS Balance Sheet | 54.5 |
| IS Earnings Quality | 57.4 |
| IS Growth | 54.7 |
| IS Value | 46.3 |
| IS Momentum | 71.7 |
| IS Safety | 72.3 |
| IS Quality | 65.5 |
| Altman Z-Score | 5.27 |
| Piotroski F-Score | 6.17 |
| Beneish M-Score | -2.47 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 1.63% |
| Payout Ratio | 63.50% |
| Buyback Yield | 1.13% |
| Total Shareholder Return | 2.23% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.671 |
| Earnings Stability | 0.287 |
| Earnings Persistence | 0.594 |
| Margin Stability | 0.940 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | 17.60 |
| Median P/B | 3.32 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 99.94% |
| Holdings Matched | 27 |
| Total Holdings | 28 |